Subject
Behavioral Neuroscience,Endocrine and Autonomic Systems,Immunology
Reference11 articles.
1. Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies;Arnone;Neurosci. Biobehav. Rev.,2018
2. Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials;Bai;J. Neurol. Neurosurg. Psychiat.,2020
3. Frodl, T., Carballedo, A., Hughes, M.M., et al. 2012. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Transl. Psychiatry. 2(3), e88, doi: 10.1038/tp.2012.14.
4. Han, K.M., Tae, W.S., Kim, A., Kang, Y., Kang, W., Kang, J., Kim, Y.K., Kim, B., Seong, J.Y., Ham, B.J., 2020. Serum FAM19A5 levels: A novel biomarker for neuroinflammation and neurodegeneration in major depressive disorders.
5. Kang, D., Kim, H.R., Kim, K.K., Kim, D.H., Jeong, B., Jin, S., Park, J.W., Seong, J.Y., Lee, B.J., 2020. Brain-specifc chemokine FAM19A5 induces hypothalamic inflammation. Biochem. Biophys. Res. Commun. 523(4), 829-834, ISSN 0006-291X, doi: 10.1016/j.bbrc.2019.12.119.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献